Scale -

  • Revenue is 25228 Rs Cr; Annual Growth is 16 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 15 %
  • Ebitda is 3961 Rs Cr; Annual Growth is 23 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 15 %
  • PBT is 785 Rs Cr; Annual Growth is 30 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 13 %
  • PAT is 1958 Rs Cr; Annual Growth is 33 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 15 %
  • Quarterly Revenue is 7044 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile

Profitability -

  • PAT Margin is 7.76 %; Annual Growth is 15 %; Continuous Growth over 3 years
  • PBDIT Margin is 15.7 %; Continuous Growth over 3 years; in Bottom Quartile
  • Quarterly Ebitda Margin is 16 %; Continuous Growth over 3 Quarters; in Bottom Quartile
  • Quarterly Profit margin is 8 %; Continuous Growth over 3 Quarters

Return -

  • ROCE is 19.62 %; Annual Growth is 28 %; Continuous Growth over 3 years; in Top Quartile
  • ROA is 8.74 %; Annual Growth is 25 %; Continuous Growth over 3 years
  • ROE is 20.48 %; Continuous Growth over 3 years; in Top Quartile
  • Asset Turnover is 118 %; in Top Quartile; 5 Year CAGR is 20 %

Efficiency -

  • Operating cash flow is 2856 Rs Cr; Annual Growth is 34 %; Continuous Growth over 3 years; in Top Quartile
  • Inventory Turnover Ratio is 49.31; Continuous Growth over 3 years
  • Current Ratio is 1.06; Annual Decline is -31 %; in Bottom Quartile
  • Quick Ratio is 0.98; Annual Decline is -31 %

Solvancy -

  • Long term Debt is 2430 Rs Cr; Annual Decline is -45 %; in Top Quartile
  • Contingent Liabilities is 2166 Rs Cr; Annual Growth is 62 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 35 %
  • Total Debt is 5658 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 21 %
  • Debt/Equity is 0.6; in Top Quartile

Quality -

  • Change in Inventories/Total Expenses is 0 %; Annual Decline is -1623 %
  • Exceptional Items/PBT is -1 %; Continuous Decline over 3 years
  • Current Tax/PAT is 32 %; Continuous Decline over 3 years
  • Other Expenses/Total Expenses is 24 %; in Bottom Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Apollo Hospitals Enterprise Ltd Sees Sharp Open Interest Surge Signalling Market Positioning Shift
Read More
  • Past/current
Apollo Hospitals Enterprise Ltd. Rallies 3.08% and Approaches 50 DMA Resistance — A Key Technical Test Ahead
Read More
  • Past/current
Buy, Sell Or Hold: Jio Platforms, Apollo Hospitals, Kaynes Tech, HDFC Bank, L&T, Tata Technologies | Ask Profit
Read More
  • Past/current
Top Gainers and Losers Today, 28 October 2026
Read More
  • Past/current
Apollo’s Total Health Model In Aragonda Shows How Rural Healthcare Can Transform Lives
Read More
  • Past/current
Apollo’s Total Health Model Transforming Rural Healthcare
Read More
  • Past/current
People should make health a priority, says Prathap Reddy
Read More
  • Past/current
Apollo Hospitals Group Associated Researchers and Clinicians Achieve Global Recognition in Stanford–Elsevier Top 2% Scientists List 2026
Read More
  • Past/current
Apollo Consumer Products names Bhubneshwar Prasad General Manager
Read More
  • Past/current
Planning to Buy Hospital Stocks? Jefferies Picks 6 Shares, Gives Target Price
Read More
  • Past/current
Fortis, Max, Apollo, Medanta, Manipal: Buy hospital stocks for 22-46% upside, says Jefferies
Read More
  • Past/current